![](https://www.oxfordinvestmentconsultants.com/wp-content/uploads/2020/09/Dr-Heiner-Dreismann-2-e1600264873869.jpg)
Dr Heiner Dreismann appointed as Chair of Biofidelity
Heiner is a former executive of Roche Diagnostics AG with more than 35 years of industry experience and a pioneer in the early adoption of polymerase chain reaction (PCR) technology. This appointment follows the completion of a $12m Series A round in 3Q 2020, in which OIC invested £350k.